Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Crosses Above 50 Day Moving Average – Time to Sell?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) shares crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $309.33 and traded as high as $310.70. Bio-Rad Laboratories shares last traded at $310.70, with a volume of 6 shares changing hands.

Bio-Rad Laboratories Stock Down 1.2%

The company has a current ratio of 5.44, a quick ratio of 3.94 and a debt-to-equity ratio of 0.18. The firm has a market capitalization of $8.38 billion, a P/E ratio of -12.78 and a beta of 1.01. The stock’s 50-day simple moving average is $309.33 and its 200-day simple moving average is $279.98.

Bio-Rad Laboratories (NYSE:BIO.B) last posted its earnings results on Wednesday, October 29th. The company reported $2.26 EPS for the quarter. The firm had revenue of $653.00 million for the quarter. Bio-Rad Laboratories had a negative net margin of 26.43% and a positive return on equity of 4.19%.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad’s product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.

In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.